Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

INDINAVIR vs INFLIXIMAB-ABDA: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

INDINAVIR vs INFLIXIMAB-ABDA: Safety Overview

Metric INDINAVIR INFLIXIMAB-ABDA
Total FAERS Reports 728 1,810
Deaths Reported 15 18
Death Rate 2.1% 1.0%
Hospitalizations 114 452
Average Patient Age 45.2 yrs 46.3 yrs
% Female Patients 29.9% 61.0%
FDA Approval Date Apr 19, 2000 N/A
Marketing Status Discontinued Prescription